POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 27, 2024

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.CANbridge Pharmaceuticals Inc.北海康成制药有限公司 (Incorporated in the Cayman Islands with limited liability) (Stock Code: 1228) POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 27 2024 The Board hereby announces that all resolutions set out in the AGM Notice were duly passed by the Shareholders by way of a poll at the AGM held on Thursday June 27 2024.ANNUAL GENERAL MEETING (THE “AGM”) Reference is made to the circular (the “AGM Circular”) and the notice of the AGM (the “AGMNotice”) of CANbridge Pharmaceuticals Inc. (the “Company”) both dated June 6 2024. Unless the context otherwise requires capitalized terms used herein shall have the same meanings as those defined in the AGM Circular.POLL RESULTS OF AGM The Board is pleased to announce that all of the proposed resolutions as set out in the AGM Notice were duly passed by the Shareholders as ordinary resolutions by way of poll at the AGM held on Thursday June 27 2024. The poll results in respect of the resolutions passed at the AGM are as follows: NO. OF VOTES ORDINARY RESOLUTIONS (APPROXIMATE%)* For Against 1. To receive and consider the audited consolidated financial 165339150 0 statements of the Company and the reports of the directors of (100.00%) (0.00%) the Company (the “Directors”) and auditor of the Company for the year ended December 31 2023. 1NO. OF VOTES ORDINARY RESOLUTIONS (APPROXIMATE%)* For Against 2. (i) To re-elect Dr. James Qun Xue as an executive Director. 123653720 0 (100.00%)(0.00%) (ii) To re-elect Dr. Kan Chen as a non-executive Director. 165339150 0 (100.00%)(0.00%) (iii) To re-elect Mr. Peng Kuan Chan as an independent non- 165339150 0 executive Director. (100.00%) (0.00%) 3. To consider the re-appointment of Ernst & Young as the auditor 165339150 0 of the Company for the year ending December 31 2024 and to (100.00%) (0.00%) authorize the Board to fix its remuneration. 4. To grant a general mandate to the Directors to issue new shares 158765150 6574000 of the Company. (96.02%) (3.98%) 5. To grant a general mandate to the Directors to repurchase 165339150 0 shares of the Company. (100.00%) (0.00%) 6. To extend the general mandate to issue new shares by adding 158765150 6574000 the number of shares repurchased. (96.02%) (3.98%) 7. To approve and adopt the amended Share Option Scheme and 117041260 6574000 authorize the Directors to handle all matters in connection with (94.68%) (5.32%) the Share Option Scheme. 8. To approve and adopt the amended RSU Scheme and authorize 117041260 6574000 the Directors to handle all matters in connection with the RSU (94.68%) (5.32%) Scheme.* All percentages are rounded to two decimal places.Please refer to the AGM Notice for the full text of the resolutions above.As more than 50% were casted in favour of each of the above ordinary resolutions numbered 1 to 8 all of the above ordinary resolutions were duly passed as ordinary resolutions of the Company.GENERAL As of the date of the AGM a total of 424838320 Shares were in issue. Dr. James Qun Xue being a Shareholder and his associates (holding a total of 41775430 Shares on an aggregate basis) were required to abstain from voting on resolution numbered 2(i) Shareholders who are holders of the outstanding Options and their respective associates (holding a total of 42113890 Shares on an aggregate basis) were required to abstain from voting on resolution numbered 7 and Shareholders who are holders of RSUs and their respective associates (holding a total of 41813890 Shares on an aggregate basis) were required to abstain from voting on resolution No. 8. As such the total number of Shares entitling the Shareholders to attend and vote for or against resolutions numbered 1 and 2(ii) to 6 2(i) 7 and 8 were 424838320 383062890 382724430 and 383024430 respectively. 2Save as disclosed above (i) there were no Shares entitling the holder to attend and abstain from voting in favour of any resolutions proposed at the AGM as set out in Rule 13.40 of the Listing Rules; (ii) no Shareholders were required to abstain from voting at the AGM under the Listing Rules; and (iii) no Shareholders have stated their intention in the AGM Circular to vote against or to abstain from voting on any of the resolutions proposed at the AGM.The Company’s share registrar in Hong Kong Computershare Hong Kong Investor Services Limited was appointed as the scrutineer at the AGM for the purpose of vote-taking. The Directors namely Dr.James Qun Xue Mr. Edward Hu Mr. James Arthur Geraghty Dr. Richard James Gregory Mr. Peng Kuan Chan and Dr. Lan Hu attended the AGM. Dr. Kan Chen did not attend the AGM due to other business arrangement.By Order of the Board CANbridge Pharmaceuticals Inc.Dr. James Qun Xue Chairman Hong Kong June 27 2024 As of the date of this announcement the Board comprises Dr. James Qun Xue as executive Director; Dr.Kan Chen and Mr. Edward Hu as non-executive Directors; and Dr. Richard James Gregory Mr. James Arthur Geraghty Mr. Peng Kuan Chan and Dr. Lan Hu as independent non-executive Directors. 3